107 related articles for article (PubMed ID: 6107564)
1. Dopamine receptors and schizophrenia: drug effect or illness?
Mackay AV; Bird ED; Spokes EG; Rossor M; Iversen LL; Creese I; Snyder SH
Lancet; 1980 Oct; 2(8200):915-6. PubMed ID: 6107564
[No Abstract] [Full Text] [Related]
2. Abnormal neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
[TBL] [Abstract][Full Text] [Related]
3. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptors, neuroleptics, and schizophrenia.
Snyder SH
Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
Wong DF; Wagner HN; Tune LE; Dannals RF; Pearlson GD; Links JM; Tamminga CA; Broussolle EP; Ravert HT; Wilson AA; Toung JK; Malat J; Williams JA; O'Tuama LA; Snyder SH; Kuhar MJ; Gjedde A
Science; 1986 Dec; 234(4783):1558-63. PubMed ID: 2878495
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder.
Cross AJ; Crow TJ; Ferrier IN; Johnstone EC; McCreadie RM; Owen F; Owens DG; Poulter M
J Neural Transm Suppl; 1983; 18():265-72. PubMed ID: 6135745
[No Abstract] [Full Text] [Related]
7. Increased dopamine-receptor sensitivity in schizophrenia.
Owen F; Cross AJ; Crow TJ; Longden A; Poulter M; Riley GJ
Lancet; 1978 Jul; 2(8083):223-6. PubMed ID: 79025
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies.
Nemeroff CB; Levant B; Myers B; Bissette G
Ann N Y Acad Sci; 1992; 668():146-56. PubMed ID: 1361110
[No Abstract] [Full Text] [Related]
9. Diminished synaptosomal dopamine (DA) release and DA autoreceptor supersensitivity in schizophrenia.
Hetey L; Schwitzkowsky R; Ott T; Barz H
J Neural Transm Gen Sect; 1991; 83(1-2):25-35. PubMed ID: 1673343
[TBL] [Abstract][Full Text] [Related]
10. Increased brain dopamine and dopamine receptors in schizophrenia.
Mackay AV; Iversen LL; Rossor M; Spokes E; Bird E; Arregui A; Creese I; Synder SH
Arch Gen Psychiatry; 1982 Sep; 39(9):991-7. PubMed ID: 7115016
[TBL] [Abstract][Full Text] [Related]
11. Central dopaminergic mechanisms in schizophrenia.
Owen F; Crow TJ; Poulter M
Acta Psychiatr Belg; 1987; 87(5):552-65. PubMed ID: 2897760
[TBL] [Abstract][Full Text] [Related]
12. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
Seeman P
Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
Creese I; Burt DR; Snyder SH
J Neuropsychiatry Clin Neurosci; 1996; 8(2):223-6. PubMed ID: 9081563
[TBL] [Abstract][Full Text] [Related]
14. Dopamine and homovanillic acid concentrations in the post-mortem brain in schizophrenia [proceedings].
Bird ED; Crow TJ; Iversen LL; Longden A; Mackay AV; Riley GJ; Spokes EG
J Physiol; 1979 Aug; 293():36P-37P. PubMed ID: 501607
[No Abstract] [Full Text] [Related]
15. [Current concepts of the effects of neuroleptics].
Kostowski W; Płaźnik A
Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
[No Abstract] [Full Text] [Related]
16. Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue.
Reisine TD; Rossor M; Spokes E; Iversen LL; Yamamura HI
Adv Biochem Psychopharmacol; 1980; 21():443-50. PubMed ID: 6246753
[No Abstract] [Full Text] [Related]
17. Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report.
Wong DF; Wagner HN; Pearlson G; Dannals RF; Links JM; Ravert HT; Wilson AA; Suneja S; Bjorvvinssen E; Kuhar MJ
Psychopharmacol Bull; 1985; 21(3):595-8. PubMed ID: 4034877
[No Abstract] [Full Text] [Related]
18. Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment.
Tsai SJ
Med Hypotheses; 2004; 63(6):1047-50. PubMed ID: 15504573
[TBL] [Abstract][Full Text] [Related]
19. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.
Mjörndal T; Winblad B
Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030
[TBL] [Abstract][Full Text] [Related]
20. Bimodal distribution of dopamine receptor densities in brains of schizophrenics.
Seeman P; Ulpian C; Bergeron C; Riederer P; Jellinger K; Gabriel E; Reynolds GP; Tourtellotte WW
Science; 1984 Aug; 225(4663):728-31. PubMed ID: 6147018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
